相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor
Youwen Zhuang et al.
CELL RESEARCH (2021)
In Vitro and In Silico Characterization of G-Protein Coupled Receptor (GPCR) Targets of Phlorofucofuroeckol-A and Dieckol
Pradeep Paudel et al.
MARINE DRUGS (2021)
Identification of a Potent and Selective Human Monoamine Oxidase-A Inhibitor, Glycitein, an Isoflavone Isolated from Pueraria lobata Flowers
Ritu Prajapati et al.
ACS FOOD SCIENCE & TECHNOLOGY (2021)
Dopamine D1 receptor antagonist reduces stimulant-induced conditioned place preferences and dopamine receptor supersensitivity
Sun Mi Gu et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Isoliquiritigenin Attenuates Anxiety-Like Behavior and Locomotor Sensitization in Rats after Repeated Exposure to Nicotine
Yuhua Wang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2020)
The antioxidant activity and neuroprotective mechanism of isoliquiritigenin
Dingding Shi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Inhibition of Butyrylcholinesterase and Human Monoamine Oxidase-B by the Coumarin Glycyrol and Liquiritigenin Isolated fromGlycyrrhiza uralensis
Geum Seok Jeong et al.
MOLECULES (2020)
Isoliquiritigenin attenuates diabetic cardiomyopathy via inhibition of hyperglycemia-induced inflammatory response and oxidative stress
Xuemei Gu et al.
PHYTOMEDICINE (2020)
Parkinson's Disease: An update on Pathophysiology, Epidemiology, Diagnosis and Management. Part 2 : Etiology and Pathophysiology
Abdulrazak Abyad
WORLD FAMILY MEDICINE (2020)
The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapy
Siew L. Cheong et al.
DRUG DISCOVERY TODAY (2019)
Simultaneous Determination and Pharmacokinetic Characterization of Glycyrrhizin, Isoliquiritigenin, Liquiritigenin, and Liquiritin in Rat Plasma Following Oral Administration of Glycyrrhizae Radix Extract
You Jin Han et al.
MOLECULES (2019)
Neuroprotective and anti-inflammatory effects of isoliquiritigenin in kainic acid-induced epileptic rats via the TLR4/MYD88 signaling pathway
Xiaobo Zhu et al.
INFLAMMOPHARMACOLOGY (2019)
Neuroprotective effects of isoliquiritigenin against cognitive impairment via suppression of synaptic dysfunction, neuronal injury, and neuroinflammation in rats with kainic acid-induced seizures
Xiaobo Zhu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases
Pamela Maher
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives
Jong Min Oh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Possible involvement of peripheral TRP channels in the hydrogen sulfide-induced hyperalgesia in diabetic rats
Jose Eduardo Roa-Coria et al.
BMC NEUROSCIENCE (2019)
MAO inhibitors and their wider applications: a patent review
Simone Carradori et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2018)
Monoamine oxidases inhibitors from Colvillea racemosa: Isolation, biological evaluation, and computational study
Enas I. Mohamed et al.
FITOTERAPIA (2018)
Exposure to Far Infrared Ray Protects Methamphetamine-Induced Behavioral Sensitization in Glutathione Peroxidase-1 Knockout Mice via Attenuating Mitochondrial Burdens and Dopamine D1 Receptor Activation
Huynh Nhu Mai et al.
NEUROCHEMICAL RESEARCH (2018)
The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement
Nicholas A. Everett et al.
NEUROPHARMACOLOGY (2018)
Protective effects of dopamine D2/D3 receptor agonist piribedil on learning and memory of rats exposed to global cerebral ischemia-reperfusion
Wenzhu Wang et al.
NEUROSCIENCE LETTERS (2018)
Isoliquiritigenin attenuates glutamate-induced mitochondrial fission via calcineurin-mediated Drp1 dephosphorylation in HT22 hippocampal neuron cells
Dong Gil Lee et al.
NEUROTOXICOLOGY (2018)
Phytochemical and Pharmacological Role of Liquiritigenin and Isoliquiritigenin From Radix Glycyrrhizae in Human Health and Disease Models
Mahesh Ramalingam et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Clinical Pharmacokinetics and Pharmacodynamics of Safinamide
Thomas Mueller et al.
CLINICAL PHARMACOKINETICS (2017)
The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Danielle O. Sambo et al.
NATURE COMMUNICATIONS (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Identification and Chemical Standardization of Licorice Raw Materials and Dietary Supplements Using UHPLC-MS/MS
Guannan Li et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Effects of isoliquiritigenin on ovarian antral follicle growth and steroidogenesis
Sharada Mahalingam et al.
REPRODUCTIVE TOXICOLOGY (2016)
A protective mechanism of licorice (Glycyrrhiza uralensis): Isoliquiritigenin stimulates detoxification system via Nrf2 activation
Hui Gong et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
Douglas E. V. Pires et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A Review: The Pharmacology of Isoliquiritigenin
Fu Peng et al.
PHYTOTHERAPY RESEARCH (2015)
Identification of Key Licorice Constituents Which Interact with Cytochrome P450: Evaluation by LC/MS/MS Cocktail Assay and Metabolic Profiling
Xue Qiao et al.
AAPS JOURNAL (2014)
Polypharmacology in a Single Drug: Multitarget Drugs
M. L. Bolognesi
CURRENT MEDICINAL CHEMISTRY (2013)
Ligand-Optimized Homology Models of D1 and D2 Dopamine Receptors: Application for Virtual Screening
Marcin Kolaczkowski et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
The role of dopamine receptors in the neurotoxicity of methamphetamine
S. Ares-Santos et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Isoliquiritigenin Isolated from Licorice Glycyrrhiza uralensis Prevents 6-Hydroxydopamine-Induced Apoptosis in Dopaminergic Neurons
Cheol Kyu Hwang et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2012)
Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration
Jean Lud Cadet et al.
CNS & Neurological Disorders-Drug Targets (2012)
HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment
Michael Remmert et al.
NATURE METHODS (2012)
Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine
S. Ares-Santos et al.
NEUROBIOLOGY OF DISEASE (2012)
Improving the Physical Realism and Structural Accuracy of Protein Models by a Two-Step Atomic-Level Energy Minimization
Dong Xu et al.
BIOPHYSICAL JOURNAL (2011)
Isoliquiritigenin is a Novel NMDA Receptor Antagonist in Kampo Medicine Yokukansan
Zenji Kawakami et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2011)
Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders
Makoto Naoi et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Ellen Y. T. Chien et al.
SCIENCE (2010)
BLAST plus : architecture and applications
Christiam Camacho et al.
BMC BIOINFORMATICS (2009)
Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective
Nicolas Guex et al.
ELECTROPHORESIS (2009)
Protective Effects of Isoliquiritigenin Against Methamphetamine-Induced Neurotoxicity in Mice
Min Jung Lee et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2009)
Dopamine receptor agonists in the treatment of advanced Parkinson's disease
Fabrizio Stocchi
PARKINSONISM & RELATED DISORDERS (2009)
Isoliquiritigenin suppresses cocaine-induced extracellular dopamine release in rat brain through GABAB receptor
Eun Young Jang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Isoliquiritigenin inhibits tumor growth and protects the kidney and liver against chemotherapy-induced toxicity in a mouse xenograft model of colon carcinoma
Chang Ki Lee et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia
Emanuela Santini et al.
JOURNAL OF NEUROSCIENCE (2007)
Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice
Nobuaki Egashira et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness
MBH Youdim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease
Matthias R. Lemke et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Impact of species-dependent differences on screening, design, and development of MAO B inhibitors
Laura Novaroli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Three-dimensional structure of human monoamine oxidase A (MAO A): Relation to the structures of rat MAO A and human MAO B
L De Colibus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice
IF Bielsky et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Genomic medicine: Alzheimer's disease and Parkinson's disease
RL Nussbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
C Binda et al.
NATURE STRUCTURAL BIOLOGY (2002)
Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding
N Cotte et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
分享论文
